Microdialysis in Lung Tissue: Monitoring of Exogenous and Endogenous Compounds

Applications of Microdialysis in Pharmaceutical Science

Volumn , Issue , 2011, Pages 255-274

  Feurstein, Thomas ^a   Zeitlinger, Markus ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Exogenous drugs lung microdialysis studies, pharmacokinetics of exogenous drugs in lung; Microdialysis in lung tissue monitoring of exogenous and endogenous compounds, microdialysis, measuring concentrations of substances; Predictability of lung concentrations measurements in tissues, muscle tissue easily accessible

Indexed keywords

EID: 84886169657     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781118011294.ch7     Document Type: Chapter

References (70)

1. Joukhadar, C., Müller, M. 2005. Microdialysis: current applications in clinical pharmacokinetic studies and its potential role in the future. Clinical Pharmacokinetics, 44, 895-913.
2. Müller, M., Schmid, R., Georgopoulos, A., Buxbaum, A., Wasicek, C., Eichler, H.G. 1995. Application of microdialysis to clinical pharmacokinetics in humans. Clinical Pharmacology & Therapeutics, 57, 371-380.
3. Ingvast-Larsson, C., Appelgren, L.E., Nyman, G. 1992. Distribution studies of theophylline: microdialysis in rat and horse and whole body autoradiography in rat. Journal of Veterinary Pharmacology and Therapeutics, 15, 386-394.
4. Tomaselli, F., Dittrich, P., Maier, A., Woltsche, M., Matzi, V., Pinter, J., Nuhsbaumer, S., Pinter, H., Smolle, J., Smolle-Juttner, F.M. 2003. Penetration of piperacillin and tazobactam into pneumonic human lung tissue measured by in vivo microdialysis. British Journal of Clinical Pharmacology, 55, 620-624.
5. Tomaselli, F., Maier, A., Matzi, V., Smolle-Juttner, F.M., Dittrich, P. 2004. Penetration of meropenem into pneumonic human lung tissue as measured by in vivo microdialysis. Antimicrobial Agents and Chemotherapy, 48, 2228-2232.
6. Hutschala, D., Kinstner, C., Skhirtladze, K., Mayer-Helm, B.X., Zeitlinger, M., Wisser, W., Müller, M., Tschernko, E. 2008. The impact of perioperative atelectasis on antibiotic penetration into lung tissue: an in vivo microdialysis study. Intensive Care Medicine, 34, 1827-1834.
7. Hutschala, D., Skhirtladze, K., Zuckermann, A., Wisser, W., Jaksch, P., Mayer-Helm, B.X., Burgmann, H., Wolner, E., Müller, M., Tschernko, E.M. 2005. In vivo measurement of levofl oxacin penetration into lung tissue after cardiac surgery. Antimicrobial Agents and Chemotherapy, 49, 5107-5111.
8. Zeitlinger, M.A., Traunmuller, F., Abrahim, A., Müller, M.R., Erdogan, Z., Müller, M., Joukhadar, C. 2007. A pilot study testing whether concentrations of levofl oxacin in interstitial space fl uid of soft tissues may serve as a surrogate for predicting its pharmacokinetics in lung. International Journal of Antimicrobial Agents, 29, 44-50.
9. Herkner, H., Müller, M.R., Kreischitz, N., Mayer, B.X., Frossard, M., Joukhadar, C., Klein, N., Lackner, E., Müller, M. 2002. Closed-chest microdialysis to measure antibiotic penetration into human lung tissue. American Journal of Respiratory and Critical Care Medicine, 165, 273-276.
10. Bergogne-Berezin, E. 1995. New concepts in the pulmonary disposition of antibiotics. Pulmonary Pharmacology & Therapeutics, 8, 65-81.
11. Gail, D.B., Lenfant, C.J. 1983. Cells of the lung: biology and clinical implications. American Review of Respiratory Disease, 127, 366-387.
12. Baldwin, D.R., Honeybourne, D., Wise, R. 1992. Pulmonary disposition of antimicrobial agents: methodological considerations. Antimicrobial Agents and Chemotherapy, 36, 1171-1175.
13. Tyvold, S.S., Solligard, E., Lyng, O., Steinshamn, S.L., Gunnes, S., Aadahl, P. 2007. Continuous monitoring of the bronchial epithelial lining fl uid by microdialysis. Respiratory Research, 8, 78.
14. Eisenberg, E.J., Conzentino, P., Eickhoff, W.M., Cundy, K.C. 1993. Pharmacokinetic measurement of drugs in lung epithelial lining fl uid by microdialysis: aminoglycoside antibiotics in rat bronchi. Journal of Pharmacological and Toxicological Methods, 29, 93-98.
15. Aoki, M., Iguchi, M., Hayashi, H., Suzuki, H., Shibasaki, S., Kurosawa, T., Hayashi, M. 2008. Proposal of membrane transport mechanism of protein-unbound ulifl oxacin into epithelial lining fl uid determined by improved microdialysis. Biological & Pharmaceutical Bulletin, 31, 1773-1777.
16. Marchand, S., Frasca, D., Dahyot-Fizelier, C., Breheret, C., Mimoz, O., Couet, W. 2008. Lung microdialysis study of levofl oxacin in rats following intravenous infusion at steady state. Antimicrobial Agents and Chemotherapy, 52, 3074-3077.
17. Tasso, L., Bettoni, C.C., Oliveira, L.K., Dalla Costa, T. 2008. Evaluation of gatifl oxacin penetration into skeletal muscle and lung by microdialysis in rats. International Journal of Pharmaceutics, 358, 96-101.
18. Zhong, H., Han, B., Tourkova, I.L., Lokshin, A., Rosenbloom, A., Shurin, M.R., Shurin, G.V. 2007. Low-dose paclitaxel prior to intratumoral dendritic cell vaccine modulates intratumoral cytokine network and lung cancer growth. Clinical Cancer Research, 13, 5455-5462.
19. Dahyot, C., Marchand, S., Pessini, G.L., Pariat, C., Debaene, B., Couet, W., Mimoz, O. 2006. Microdialysis study of imipenem distribution in skeletal muscle and lung extracellular fl uids of Acinetobacter baumannii-infected rats. Antimicrobial Agents and Chemotherapy, 50, 2265-2267.
20. Liu, P., Fuhrherr, R., Webb, A.I., Obermann, B., Derendorf, H. 2005. Tissue penetration of cefpodoxime into the skeletal muscle and lung in rats. European Journal of Pharmaceutical Sciences, 25, 439-444.
21. Marchand, S., Dahyot, C., Lamarche, I., Mimoz, O., Couet, W. 2005. Microdialysis study of imipenem distribution in skeletal muscle and lung extracellular fl uids of noninfected rats. Antimicrobial Agents and Chemotherapy, 49, 2356-2361
22. Eichler, W., Bechtel, M.J., Klaus, S., Heringlake, M., Hernandez, M., Toerber, K., Klotz, K.F., Bartels, C. 2004. Na + /H + exchange inhibitor cariporide: effects on respiratory dysfunction after cardiopulmonary bypass. Perfusion, 19, 33-40.
23. Grubb, B.R., Jones, J.H., Boucher, R.C. 2004. Mucociliary transport determined by in vivo microdialysis in the airways of normal and CF mice. American Journal of Physiology: Lung Cellular and Molecular Physiology, 286, L588-L595.
24. Liu, P., Müller, M., Grant, M., Webb, A.I., Obermann, B., Derendorf, H. 2002. Interstitial tissue concentrations of cefpodoxime. Journal of Antimicrobial Chemotherapy, 50 Suppl., 19-22.
25. de la Peña, A., Dalla Costa, T., Talton, J.D., Rehak, E., Gross, J., Thyroff-Friesinger, U., Webb, A.I., Müller, M., Derendorf, H. 2001. Penetration of cefaclor into the interstitial space fl uid of skeletal muscle and lung tissue in rats. Pharmaceutical Research, 18, 1310-1314.
26. Pan, Y.F., Feng, J., Cheng, Q.Y., Li, F.Z. 2007. Intracerebral microdialysis technique and its application on brain pharmacokinetic-pharmacodynamic study. Archives of Pharmacal Research, 30, 1635-1645.
27. Borjigin, J., Liu, T. 2008. Application of long-term microdialysis in circadian rhythm research. Pharmacology Biochemistry and Behavior, 90, 148-155.
28. Linthorst, A.C., Reul, J.M. 2008. Stress and the brain: solving the puzzle using microdialysis. Pharmacology Biochemistry and Behavior, 90, 163-173.
29. Neumann, I.D. 2007. Stimuli and consequences of dendritic release of oxytocin within the brain. Biochemical Society Transactions, 35, 1252-1257.
30. Afzelius, B.A. 1976. A human syndrome caused by immotile cilia. Science, 193,317-319.
31. Robinson, M., Bye, P.T. 2002. Mucociliary clearance in cystic fi brosis. Pediatric Pulmonology, 33, 293-306.
32. Wienkotter, N., Begrow, F., Kinzinger, U., Schierstedt, D., Verspohl, E.J. 2007. The effect of thyme extract on beta2-receptors and mucociliary clearance. Planta Medica, 73, 629-635.
33. Wienkotter, N., Hopner, D., Schutte, U., Bauer, K., Begrow, F., El-Dakhakhny, M., Verspohl, E.J. 2008. The effect of nigellone and thymoquinone on inhibiting trachea contraction and mucociliary clearance. Planta Medica, 74, 105-108.
34. Larsson, C.I. 1991. The use of an " internal standard " for control of the recovery in microdialysis. Life Sciences, 49, PL73-PL78.
35. Vincent, J.L., Bihari, D.J., Suter, P.M., Bruining, H.A., White, J., Nicolas-Chanoin, M.H., Wolff, M., Spencer, R.C., Hemmer, M. 1995. The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care EPIC Study. EPIC International Advisory Committee. Journal of the American Medical Association, 274, 639-644.
36. Bartlett, J.G., Mundy, L.M. 1995. Community-acquired pneumonia. New England Journal of Medicine, 333, 1618-1624.
37. Zeitlinger, M.A., Dehghanyar, P., Mayer, B.X., Schenk, B.S., Neckel, U., Heinz, G., Georgopoulos, A., Müller, M., Joukhadar, C. 2003. Relevance of soft-tissue penetration by levofl oxacin for target site bacterial killing in patients with sepsis. Antimicrobial Agents and Chemotherapy, 47, 3548-3553.
38. Joukhadar, C., Frossard, M., Mayer, B.X., Brunner, M., Klein, N., Siostrzonek, P., Eichler, H.G., Müller, M. 2001. Impaired target site penetration of beta-lactams may account for therapeutic failure in patients with septic shock. Critical Care Medicine, 29, 385-391.
39. Lambert, H.P. 1978. Clinical signifi cance of tissue penetration of antibiotics in the respiratory tract. Scandinavian Journal of Infectious Diseases Supplementum,262-266.
40. Craig, W.A. 1998. Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men. Clinical Infectious Diseases, 26, 1-10; quiz,11-12.
41. Drusano, G.L., Craig, W.A. 1997. Relevance of pharmacokinetics and pharmacodynamics in the selection of antibiotics for respiratory tract infections. Journal of Chemotherapy, 9 Suppl. 3, 38-44.
42. Schentag, J.J. 1990. Correlation of pharmacokinetic parameters to effi cacy of antibiotics: relationships between serum concentrations, MIC values, and bacterial eradication in patients with gram-negative pneumonia. Scandinavian Journal of Infectious Diseases Supplementum, 74, 218-234.
43. European Agency for the Evaluation of Medicinal Products 2000. Points to consider on pharmacokinetics and pharmacodynamics in the development of antibacterial medicinal products. http://www.emea.eu.int/pdfs/human/ewp/265599en.pdf.
44. U.S. Food and Drug Administration 1998. Guidance for Industry: Developing antimicrobial drugs-general considerations for clinical trials. http://www.fda. gov/cder/guidance/2580dft.pdf.
45. Ren, Y.C., Wang, L., He, H.B., Tang, X. 2009. Pulmonary selectivity and local pharmacokinetics of ambroxol hydrochloride dry powder inhalation in rat. Journal of Pharmaceutical Sciences, 98, 1797-1803.
46. Marlin, G.E., Burgess, K.R., Burgoyne, J., Funnell, G.R., Guinness, M.D. 1981. Penetration of piperacillin into bronchial mucosa and sputum. Thorax, 36,774-780.
47. Bergogne-Bérézin, E., Muller-Serieys, C., Aubier, M., Dombret, M.C. 1994. Concentration of meropenem in serum and in bronchial secretions in patients undergoing fi breoptic bronchoscopy. European Journal of Clinical Pharmacology, 87-88.
48. Brun, Y., Forey, F., Gamondes, J.P., Tebib, A., Brune, J., Fleurette, J. 1981. Levels of erythromycin in pulmonary tissue and bronchial mucus compared to those of amoxycillin. Journal of Antimicrobial Chemotherapy, 8, 459-466.
49. Klastersky, J., Thys, J.P., Mombelli, G. 1981. Comparative studies of intermittent and continuous administration of aminoglycosides in the treatment of bronchopulmonary infections due to gram-negative bacteria. Reviews of Infectious Disease, 74-83.
50. Cole, D.R., Pung, J. 1977. Penetration of cefazolin into pleural fl uid. Antimicrobial Agents and Chemotherapy, 11, 1033-1035.
51. Byl, B., Jacobs, F., Roucloux, I., de Franquen, P., Cappello, M., Thys, J.P. 1999. Penetration of meropenem in lung, bronchial mucosa, and pleural tissues. Antimicrobial Agents and Chemotherapy, 43, 681-682.
52. Valcke, Y., Pauwels, R., Van der Straeten, M. 1990. The penetration of aminoglycosides into the alveolar lining fl uid of rats: the effect of airway infl ammation. American Review of Respiratory Disease, 142, 1099-1103.
53. Panteix, G., Harf, R., Desnottes, J.F., Gosselet, H., Leclercq, M., Diallo, N., Couprie, N., Desbos, A., Perrin Fayolle, M., Ballereau, M. 1994. Accumulation of pefl oxacin in the lower respiratory tract demonstrated by bronchoalveolar lavage. Journal of Antimicrobial Chemotherapy, 33, 979-985.
54. Allegranzi, B., Cazzadori, A., Di Perri, G., Bonora, S., Berti, M., Franchino, L., Biglino, A., Cipriani, A., Concia, E. 2000. Concentrations of single-dose meropenem 1 g iv in bronchoalveolar lavage and epithelial lining fl uid. Journal of Antimicrobial Chemotherapy, 46, 319-322.
55. Harf, R., Panteix, G., Desnottes, J.F., Diallo, N., Leclercq, M. 1988. Spiramycin uptake by alveolar macrophages. Journal of Antimicrobial Chemotherapy,Suppl. B, 135-140.
56. Le Conte, P., Potel, G., Peltier, P., Horeau, D., Caillon, J., Juvin, M.E., Kergueris, M.F., Bugnon, D., Baron, D. 1993. Lung distribution and pharmacokinetics of aerosolized tobramycin. American Review of Respiratory Disease, 147, 1279-1282.
57. Wollmer, P., Pride, N.B., Rhodes, C.G., Sanders, A., Pike, V.W., Palmer, A.J., Silvester, D.J., Liss, R.H. 1982. Measurement of pulmonary erythromycin concentration in patients with lobar pneumonia by means of positron tomography. Lancet, 2, 1361-1364.
58. Brunner, M., Langer, O., Dobrozemsky, G., Müller, U., Zeitlinger, M., Mitterhauser, M., Wadsak, W., Dudczak, R., Kletter, K., Müller, M. 2004. FCiprofl oxacin, a new positron emission tomography tracer for noninvasive assessment of the tissue distribution and pharmacokinetics of ciprofl oxacin in humans. Antimicrobial Agents and Chemotherapy, 48, 3850-3857.
59. Braude, A.C., Hornstein, A., Klein, M., Vas, S., Rebuck, A.S. 1983. Pulmonary disposition of tobramycin. American Review of Respiratory Disease, 127,563-565.
60. Decre, D., Bergogne-Bérézin, E. 1993. Pharmacokinetics of quinolones with special reference to the respiratory tree. Journal of Antimicrobial Chemotherapy, 331-343.
61. Kunin, C.M. 1967. Clinical signifi cance of protein binding of the penicillins. Annals of the New York Academy of Sciences, 145, 282-290.
62. DeGuchi, Y., Terasaki, T., Yamada, H., Tsuji, A. 1992. An application of microdialysis to drug tissue distribution study: in vivo evidence for free-ligand hypothesis and tissue binding of beta-lactam antibiotics in interstitial fl uids. Journal of Pharmacobio-Dynamics, 15, 79-89.
63. Nix, D.E., Goodwin, S.D., Peloquin, C.A., Rotella, D.L., Schentag, J.J. 1991. Antibiotic tissue penetration and its relevance: impact of tissue penetration on infection response. Antimicrobial Agents and Chemotherapy, 35, 1953-1959.
64. Poulin, P., Theil, F.P. 2000. A priori prediction of tissue: plasma partition coeffi -cients of drugs to facilitate the use of physiologically-based pharmacokinetic models in drug discovery. Journal of Pharmaceutical Sciences, 89, 16-35.
65. Zeitlinger, M., Müller, M., Joukhadar, C. 2005. Lung microdialysis: a powerful tool for the determination of exogenous and endogenous compounds in the lower respiratory tract. American Association of Pharmaceutical Scientists, 7, E600-8.
66. Gotfried, M.H., Danziger, L.H., Rodvold, K.A. 2001. Steady-state plasma and intrapulmonary concentrations of levofl oxacin and ciprofl oxacin in healthy adult subjects. Chest, 119, 1114-1122.
67. Fujita, A., Miya, T., Tanaka, R., Hirayama, S., Isaka, H., Ono, Y., Koshiishi, Y., Goya, T. 1999. Levofl oxacin concentrations in serum, sputum and lung tissue: evaluation of its effi cacy according to breakpoint. Japanese Journal of Antibiotics, 52,661-666.
68. Boselli, E., Breilh, D., Cannesson, M., Xuereb, F., Rimmele, T., Chassard, D., Saux, M.C., Allaouchiche, B. 2004. Steady-state plasma and intrapulmonary concentrations of piperacillin/tazobactam 4 g/0.5 g administered to critically ill patients with severe nosocomial pneumonia. Intensive Care Medicine, 30, 976-979.
69. Jehl, F., Muller-Serieys, C., de Larminat, V., Monteil, H., Bergogne-Bérézin, E. 1994. Penetration of piperacillin-tazobactam into bronchial secretions after multiple doses to intensive care patients. Antimicrobial Agents and Chemotherapy, 2780-2784.
70. Joukhadar, C., Klein, N., Mayer, B.X., Kreischitz, N., Delle-Karth, G., Palkovits, P., Heinz, G., Müller, M. 2002. Plasma and tissue pharmacokinetics of cefpirome in patients with sepsis. Critical Care Medicine, 30, 1478-1482.